Form 4: Constellium Director Reports Late Share Purchase

Sentiment:

Insider Transaction Report


Constellium SE Director Jean-Christophe Deslarzes reported a purchase of 1,665 ordinary shares at $24.77 each, with the Form 4 filed late on March 17, 2026, for a transaction dated March 2, 2026.

Delay expectedThe filing of the Form 4 itself was delayed, submitted on March 17, 2026, for a transaction dated March 2, 2026, missing the two-business-day SEC deadline for reporting insider transactions.
Worse than expectedThe Form 4 was filed on March 17, 2026, for a transaction that occurred on March 2, 2026, exceeding the SEC's two-business-day filing requirement, which is a negative compliance event.

Summary

  • Jean-Christophe Deslarzes, a Director of Constellium SE (CSTM), acquired 1,665 ordinary shares.
  • The purchase price for these shares was $24.77 per share.
  • The transaction occurred on March 2, 2026.
  • The acquisition was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
  • Following this transaction, Deslarzes beneficially owns 40,700 ordinary shares directly.
  • The Form 4 filing was made on March 17, 2026, which is beyond the two-business-day deadline for reporting such transactions to the SEC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative event. While the insider purchase itself is a positive signal of confidence, the late filing of the Form 4 raises concerns about corporate governance and compliance, offsetting the positive sentiment.

Positives

  • A director's purchase of shares can signal confidence in the company's future prospects and valuation.
  • The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned acquisition rather than a reaction to immediate non-public news.

Negatives

  • The Form 4 was filed late on March 17, 2026, for a transaction that occurred on March 2, 2026, violating the SEC's two-business-day reporting requirement.

Risks

  • Late filing of a Form 4 can indicate a lapse in internal compliance procedures or oversight regarding insider trading regulations.
  • Potential for regulatory scrutiny or fines due to non-compliance with SEC filing deadlines.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of a past insider transaction.

Industry Context

StockSavvy.ai notes that while insider buying generally signals confidence, the late filing of this Form 4 introduces a compliance concern. This contrasts with best practices for corporate governance, where timely disclosure of insider transactions is paramount for market transparency, especially in the aluminum products manufacturing sector where Constellium SE operates.

Comparison to Industry Standards

  • Insider buying activity is a common occurrence across all industries, often viewed as a positive signal.
  • The use of a Rule 10b5-1 plan is a standard practice for insiders to buy or sell shares in a pre-scheduled manner, mitigating concerns about trading on material non-public information.
  • However, timely filing of Form 4s within two business days is a strict regulatory requirement across all publicly traded companies in the U.S. A late filing, as observed here, deviates from industry best practices for regulatory compliance and transparency, regardless of the industry.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compliance IssueLate filing of Form 4 for Director Jean-Christophe Deslarzes' share purchase.03/17/2026Indicates a potential lapse in internal controls or oversight regarding SEC reporting requirements for insider transactions, which could lead to regulatory scrutiny.

Related Party Transactions

  • The reported transaction is a related party dealing, as it involves a director of Constellium SE purchasing company shares.

Stakeholder Impact

  • Shareholders may view the director's purchase as a positive indicator of management confidence, but the late filing could raise concerns about transparency and corporate governance.
  • Regulators, specifically the SEC, may scrutinize the late filing for non-compliance with Section 16(a) reporting requirements.

Key Dates

DateDescription
03/02/2026Transaction date for the acquisition of ordinary shares by Jean-Christophe Deslarzes.
03/17/2026Date the Form 4 was signed and filed by the attorney-in-fact, reporting the transaction.

Recommendation

hold

While the director's purchase of shares under a 10b5-1 plan typically signals confidence, the late filing of the Form 4 is a compliance issue that introduces uncertainty and potential governance concerns. This mixed signal suggests a 'hold' recommendation, advising investors to monitor for further information regarding the company's compliance practices and overall financial performance before making a definitive investment decision.

Keywords

Constellium SE, CSTM, Insider Trading, Form 4, Share Purchase, Director, Jean-Christophe Deslarzes, 10b5-1 Plan, Late Filing, SEC Compliance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.